These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 17267329)

  • 1. New therapeutic approaches for metastatic thyroid carcinoma.
    Baudin E; Schlumberger M
    Lancet Oncol; 2007 Feb; 8(2):148-56. PubMed ID: 17267329
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Juvenile differentiated thyroid carcinoma and the role of radioiodine in its treatment: a qualitative review.
    Jarzab B; Handkiewicz-Junak D; Wloch J
    Endocr Relat Cancer; 2005 Dec; 12(4):773-803. PubMed ID: 16322322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. rhTSH-aided radioiodine ablation and treatment of differentiated thyroid carcinoma: a comprehensive review.
    Luster M; Lippi F; Jarzab B; Perros P; Lassmann M; Reiners C; Pacini F
    Endocr Relat Cancer; 2005 Mar; 12(1):49-64. PubMed ID: 15788638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Update on the diagnosis and therapy of distant metastases of differentiated thyroid carcinoma.
    Zanotti-Fregonara P; Hindié E; Faugeron I; Moretti JL; Ravasi L; Rubello D; Toubert ME
    Minerva Endocrinol; 2008 Dec; 33(4):313-27. PubMed ID: 18923368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Radioiodine therapy and radioiodine after-care in differentiated thyroid gland carcinomas].
    Börner AR; Müller-Gärtner HW
    Zentralbl Chir; 1997; 122(4):274-85. PubMed ID: 9221638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Use of recombinant human TSH for stimulation of iodine radioisotope uptake in metastases of thyroid cancer during therapy with 131I].
    Roskosz J; Handkiewicz-Junak D; Turska M; Wygoda Z; Jurecka-Tuleja B; Jarzab B
    Wiad Lek; 2001; 54 Suppl 1():289-96. PubMed ID: 12182037
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lithium as adjuvant to radioiodine therapy in differentiated thyroid carcinoma: clinical and in vitro studies.
    Liu YY; van der Pluijm G; Karperien M; Stokkel MP; Pereira AM; Morreau J; Kievit J; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2006 Jun; 64(6):617-24. PubMed ID: 16712662
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Standard and emerging therapeutic approaches for thyroid malignancies.
    Brown RL
    Semin Oncol; 2008 Jun; 35(3):298-308. PubMed ID: 18544444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correlation of clinicopathological features and expression of molecular markers with prognosis after ¹³¹I treatment of differentiated thyroid carcinoma.
    Qin C; Cau W; Zhang Y; Mghanga FP; Lan X; Gao Z; An R
    Clin Nucl Med; 2012 Mar; 37(3):e40-6. PubMed ID: 22310269
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Total thyroidectomy and adjuvant radioiodine treatment independently decrease locoregional recurrence risk in childhood and adolescent differentiated thyroid cancer.
    Handkiewicz-Junak D; Wloch J; Roskosz J; Krajewska J; Kropinska A; Pomorski L; Kukulska A; Prokurat A; Wygoda Z; Jarzab B
    J Nucl Med; 2007 Jun; 48(6):879-88. PubMed ID: 17536106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radioiodine therapy after pretreatment with bexarotene for metastases of differentiated thyroid carcinoma.
    Liu YY; Stokkel MP; Morreau HA; Pereira AM; Romijn JA; Smit JW
    Clin Endocrinol (Oxf); 2008 Apr; 68(4):605-9. PubMed ID: 17986279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Metastases of a medullary carcinoma of the thyroid (follicular variant). Diagnosis and therapy using radioiodine].
    Ruhlmann J; Vogel J; Bockisch A; Biersack HJ
    Dtsch Med Wochenschr; 1987 Jul; 112(30):1170-2. PubMed ID: 3608841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radioiodine therapy for thyroid cancer in the era of risk stratification and alternative targeted therapies.
    Pryma DA; Mandel SJ
    J Nucl Med; 2014 Sep; 55(9):1485-91. PubMed ID: 25134528
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Radioiodine therapy in differentiated thyroid gland carcinoma].
    Schicha H; Dietlein M
    Zentralbl Chir; 1997; 122(4):266-73. PubMed ID: 9221637
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiated thyroid cancer. Impact of adjuvant external radiotherapy in patients with perithyroidal tumor infiltration (stage pT4).
    Farahati J; Reiners C; Stuschke M; Müller SP; Stüben G; Sauerwein W; Sack H
    Cancer; 1996 Jan; 77(1):172-80. PubMed ID: 8630926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radioiodine therapy of advanced differentiated thyroid cancer: clinical considerations and multidisciplinary approach.
    Giovanella L; Scappaticcio L
    Q J Nucl Med Mol Imaging; 2019 Sep; 63(3):229-234. PubMed ID: 31271270
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical trials for progressive differentiated thyroid cancer: patient selection, study design, and recent advances.
    Schlumberger M; Sherman SI
    Thyroid; 2009 Dec; 19(12):1393-400. PubMed ID: 20001721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. New approaches in the management of radioiodine-refractory thyroid cancer: the molecular targeted therapy era.
    Capdevila J; Argiles G; Rodriguez-Frexinos V; Nuñez I; Tabernero J
    Discov Med; 2010 Feb; 9(45):153-62. PubMed ID: 20193642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Diagnosis, treatment and follow-up in the case of differentiated thyroid cancer].
    Lind P; Igerc I; Kohlfürst S
    Wien Med Wochenschr; 2005 Oct; 155(19-20):429-35. PubMed ID: 16424998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dosimetrically determined doses of radioiodine for the treatment of metastatic thyroid carcinoma.
    Van Nostrand D; Atkins F; Yeganeh F; Acio E; Bursaw R; Wartofsky L
    Thyroid; 2002 Feb; 12(2):121-34. PubMed ID: 11916281
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.